Metadate CD en es it fr

Metadate CD Brand names, Metadate CD Analogs

Metadate CD Brand Names Mixture

  • No information avaliable

Metadate CD Chemical_Formula


Metadate CD RX_link

Metadate CD fda sheet

Metadate_CD FDA

Metadate CD msds (material safety sheet)

Metadate_CD MSDS

Metadate CD Synthesis Reference

M. Hartmann, L. Panizzon, U.S. Pat. 2,507,631 (1950)

Metadate CD Molecular Weight

233.306 g/mol

Metadate CD Melting Point


Metadate CD H2O Solubility


Metadate CD State


Metadate CD LogP


Metadate CD Dosage Forms

Tablets; Tablets (sustained release)

Metadate CD Indication

For use as an integral part of a total treatment program which typically includes other remedial measures (psychological, educational, social) for a stabilizing effect in children with a behavioral syndrome characterized by the following group of developmentally inappropriate symptoms: moderate-to-severe distractibility, short attention span, hyperactivity, emotional lability, and impulsivity.

Metadate CD Pharmacology

Methylphenidate is a central nervous system stimulant used most commonly in the treatment of attention-deficit disorders in children and for narcolepsy. Its mechanisms appear to be similar to those of dextroamphetamine.

Metadate CD Absorption

Readily absorbed in a biphasic manner. It reaches peak absorption at approximately two hours for the first phase and five hours for the second phase. Bioavailability is low (approximately 30%)

Metadate CD side effects and Toxicity

Symptoms of overdose include vomiting, agitation, tremors, hyperreflexia, muscle twitching, convulsions (may be followed by coma), euphoria, confusion, hallucinations, delirium, sweating, flushing, headache, hyperpyrexia, tachycardia, palpitations, cardiac arrhythmias, hypertension, mydriasis, and dryness of mucous membranes. LD50=190mg/kg (orally in mice)

Metadate CD Patient Information

Metadate CD Organisms Affected

Humans and other mammals